RLAY Latest Headlines

Top and lowest-rated mid-cap stocks heading into earnings

at seekingalpha.com (Mon, 13-Apr 9:35 AM)

Relay Therapeutics Highlights Strong Efficacy and Tolerability for Zovegalisib at Phase 3 Dose in PI3Ka-Mutant Breast Cancer

Market Chameleon (Mon, 16-Mar 7:53 AM)

Relay Therapeutics Poised for Impact as Biliary Tract Cancer Market Set for 10.1% CAGR Growth Through 2034

Market Chameleon (Tue, 3-Mar 7:42 AM)

Relay Therapeutics Outlines Major 2026 Milestones as Cash Reserves Remain Robust and Clinical Data Builds Momentum

Market Chameleon (Fri, 27-Feb 11:52 AM)

Relay Therapeutics Sets Stage for Major Clinical Milestones in 2026 on Solid Financial Ground

Market Chameleon (Fri, 27-Feb 8:59 AM)

Relay Therapeutics Sets Financial Results Date as Phase 3 Trials on Zovegalisib Progress

Market Chameleon (Fri, 20-Feb 8:40 AM)

FDA Breakthrough Therapy Designation Positions Relay’s Zovegalisib as Potential Game-Changer for Advanced Breast Cancer

Market Chameleon (Tue, 3-Feb 7:38 AM)